SGCB and heart failure: Poor response to natriuretic peptides leads to worsening of the vicious cycle of neurohormonal activation in heart failure. Due to this disruption in the NO-sGC-cGMP signaling pathway, there is a rationale for the development of newer drugs in heart failure to target it.